FDA released a warning letter regarding device failures involving Beta Bionics, Inc.
3 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
FDA released a warning letter regarding device failures involving Beta Bionics, Inc.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.FDA issued Form 483 and warning letters concerning Beta Bionics' iLet Bionic Pancreas.1 source
FDA issued a warning letter to Beta Bionics, Inc. over device failures.1 source
Keep exploring
The entities involved
Related events
- FDA classified a device failure involving ERBE as Class 2 on August 27, 2026.
- FDA safety warnings have been issued, causing caution among clinicians.
- The Food and Drug Administration (FDA) oversees product safety and recalls.
- The FDA posted a notice regarding product contamination involving Par Pharmaceutical.
- FDA approval is the goal for product candidates from Daré Bioscience, Inc.